Makindo Medical Notes"One small step for man, one large step for Makindo" |
|
|---|---|
| Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
| MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
Ketones (or ketone bodies) are small, water-soluble molecules produced by the liver during periods of low carbohydrate availability. They act as an alternative energy substrate and useful alternative fuel when glucose supply is reduced, particularly for the brain, myocardium, and skeletal muscle. The three physiologically relevant ketone bodies are acetoacetate, β-hydroxybutyrate, and acetone.
Ketogenesis occurs in hepatic mitochondria when insulin levels are low and counter-regulatory hormones (glucagon, cortisol, catecholamines) are high. Increased lipolysis releases free fatty acids, which undergo β-oxidation to acetyl-CoA. When acetyl-CoA exceeds the capacity of the TCA cycle (often due to oxaloacetate depletion), it is diverted into ketone body synthesis.
Ketones are a normal and adaptive response to fasting, prolonged exercise, and carbohydrate restriction. After 24–72 hours of fasting, the brain increasingly relies on ketones, reducing its dependence on glucose and limiting muscle protein breakdown for gluconeogenesis. Importantly, ketones cross the blood–brain barrier via monocarboxylate transporters.
Ketone levels must always be interpreted alongside glucose, pH, bicarbonate, and the clinical picture. In UK practice, blood ketones (β-hydroxybutyrate) are preferred because they reflect real-time ketogenesis and correlate with severity of metabolic decompensation.
These levels are considered physiological and are commonly seen in the fed state. Even in short fasting or overnight illness, values usually remain below this threshold and are not associated with acidosis.
This range suggests increased fat metabolism and may be seen with fasting, intercurrent illness, vomiting, or reduced carbohydrate intake. In people with diabetes, this should prompt increased monitoring, hydration, and review of insulin, as it may represent evolving insulin deficiency.
Blood ketones at or above 3.0 mmol/L strongly suggest diabetic ketoacidosis when accompanied by hyperglycaemia and metabolic acidosis (pH < 7.3 and/or bicarbonate < 15 mmol/L). At this level, ketone production has overwhelmed buffering capacity, leading to acidemia and systemic illness.
Ketones alone do not diagnose DKA. A patient with mild ketonaemia and normal pH is very different from a patient with ketones ≥ 3.0 mmol/L, rising glucose, dehydration, and tachypnoea. Always integrate ketone levels with acid–base status and overall physiology before escalating treatment.